Finally, a report on the aggressive mantle cell lymphoma (MCL) in patients treated with R-HyperCVAD over a ten-year follow-up identified significant associations between the overall survival and three GSTO1 polymorphisms (rs1147611, rs4925, rs2164624) as well as two GSTO2 polymorphisms (rs156697, rs157080) [114]. Here, GSTO2 is linked to mantle cell lymphoma.